EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 166 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,059,539 | +2.3% | 67,187 | +26.1% | 0.03% | 0.0% |
| Q2 2023 | $1,035,705 | +140.8% | 53,277 | +251.5% | 0.03% | +125.0% |
| Q1 2023 | $430,032 | -6.5% | 15,158 | +37.5% | 0.01% | -71.4% |
| Q1 2021 | $460,000 | -42.9% | 11,027 | -41.8% | 0.04% | -19.2% |
| Q3 2020 | $805,000 | -11.3% | 18,954 | -4.0% | 0.05% | -21.2% |
| Q1 2020 | $908,000 | +105.4% | 19,739 | +125.5% | 0.07% | +112.9% |
| Q1 2019 | $442,000 | -48.7% | 8,753 | -59.1% | 0.03% | -42.6% |
| Q4 2018 | $862,000 | +254.7% | 21,405 | +510.2% | 0.05% | +200.0% |
| Q3 2018 | $243,000 | – | 3,508 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |